Lyfius Pharma Private Limited

Lyfius Pharma Private Limited - pharma in Visakhapatnam, Andhra Pradesh, India. FY 2026 financials & compliance.
CIN U24299AP2020PTC116443 Incorporated 16 November 2020 ROC Vijayawada HQ Visakhapatnam, Andhra Pradesh, India
Active Private Limited Company pharma
Revenue · FY 2023
₹1.95 Lakh
Latest filing
Net loss · FY 2023
₹11.19 Cr
Latest filing
EBITDA · FY 2023
-₹40.78 Lakh
Latest filing
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹1,550 Cr
Satisfied ₹700 Cr
Company age
6 yrs
Est. 2020
Employees · EPFO
962
Provident fund records

About Lyfius Pharma Private Limited

Data last updated:

Lyfius Pharma Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India, a subsidiary of Aurobindo Antibiotics Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 November 2020 and has been in existence for over 6 years.

Its director Nityananda Reddy and family are #389 among India's richest people (2026).

The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24299AP2020PTC116443. Its GSTIN is 37AAECL4415B1ZX (Andhra Pradesh).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Medisetti Venkata Ramakrishna (Whole-Time Director) and Santhanam Subramanian.

Its last annual general meeting (AGM) was held on 08 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit 14 Jn Pharma City Plot No 17 Rno.10 11 & 19 20 E Bonangi Vlg, Visakhapatnam, Andhra Pradesh, India – 531021.

As per the financials filed for FY 2023, the company reported a revenue of ₹1.95 Lakh. For the same year it recorded a net loss of ₹11.19 Cr and EBITDA of -₹40.78 Lakh.

The company has about 962 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹1,550 Cr and satisfied charges of ₹700 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 1 case is pending.

For more details, the company can be reached via its website aurobindo.com.

Company details

CIN U24299AP2020PTC116443
Registration Number 116443
Incorporation Date 16 November 2020
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Parent Company Aurobindo Antibiotics Private Limited

Recognitions & Rankings of Lyfius Pharma

Contact details

Lyfius Pharma Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Unit 14 Jn Pharma City Plot No 17 Rno.10 11 & 19 20 E Bonangi Vlg, Visakhapatnam, Andhra Pradesh, India – 531021
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Lyfius Pharma Private Limited, buy the company report.

Comprehensive company report
Lyfius Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Lyfius Pharma Private Limited

FY 2025 filings available

Lyfius Pharma Private Limited reported revenue of ₹1.95 Lakh for FY 2023.

Revenue · FY 2023
₹1.95 Lakh
Net loss · FY 2023
₹11.19 Cr
EBITDA · FY 2023
-₹40.78 Lakh

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹1.95 Lakh
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹40.78 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹11.19 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Lyfius Pharma Private Limited, buy the company report.

Board of directors of Lyfius Pharma Private Limited

Lyfius Pharma has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Medisetti Venkata RamakrishnaWhole-Time Director25 Apr 20224 Years 6 MonthsCurrent
Santhanam SubramanianDirector16 Nov 20206 Years 0 MonthsCurrent
Bala Subramanyam Sami Reddy Palle ReddyAdditional Director14 Nov 20251 Years 0 MonthsCurrent
Nityananda Reddy KambamDirector01 Dec 20232 Years 11 MonthsCurrent
Srinivasa Ramachandra Rao IlapakurthyDirector30 Jan 20242 Years 9 MonthsCurrent

Auditor

Lyfius Pharma Private Limited is audited by G P M & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
G P M & ASSOCIATESFY 2023015343S

Shareholding

The shareholding of Lyfius Pharma Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Lyfius Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1,550 Cr
Satisfied charges
₹700 Cr
Breakdown by lending institutions
Others₹1,250.00 Cr
Hdfc Bank Limited₹150.00 Cr
Yes Bank Limited₹150.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
23 Sep 2024100988719Yes Bank Limited₹150 CrOpen
31 Jul 2024100957346Hdfc Bank Limited₹150 CrOpen
30 Dec 2022100672468Others₹1,250 CrOpen
04 Nov 2024101020599State Bank of India₹450 CrSatisfied
15 Jul 2022100593791Hdfc Bank Limited₹250 CrSatisfied

To see the full charge records of Lyfius Pharma Private Limited, buy the company report.

Total charge records: 5 View all charges

MSME payment delays

Lyfius Pharma Private Limited has 6 MSME Form 1 returns on record between 2022 and 2024, listing 116 overdue payments to 47 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 47)

SupplierAmount dueDue sinceReported on
Trinitech Infrastructure (India) Private Limited
an individual supplier
Vinair Systems Private Limited
Biolaxi Enzymes Private Limited
CK Enterprises LLP

To see the full MSME payment records of Lyfius Pharma Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Lyfius Pharma Private Limited has a workforce of 962 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
962
Active EPFO establishments
1
Employee growth
9.9%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27962
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

To see the full employee and EPFO history of Lyfius Pharma Private Limited, buy the company report.

GST

Lyfius Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
37AAECL4415B1ZXAndhra PradeshActive07 Jun 2021

To see the full GST registrations and return filing status of Lyfius Pharma Private Limited, buy the company report.

Recent activity

Lyfius Pharma Private Limited has 9 board changes on record since 2020: 7 appointments and 2 cessations. The latest: Bala Subramanyam Sami Reddy Palle Reddy was appointed as Additional Director on 14 Nov 2025.

Charges
A charge registered on 04 Nov 2024 via Charge ID 101020599 with State Bank Of India was fully satisfied on 19 Jan 2026.
Appointed
Bala Subramanyam Sami Reddy Palle Reddy was appointed as Additional Director.
AGM
Lyfius Pharma Private Limited last Annual general meeting of members was held on 08 Sep 2025 as per latest MCA records.
Filing
Lyfius Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada.
Charges
A charge with State Bank Of India amounted to Rs. 45,000.00 Lakh with Charge ID 101020599 was registered on 04 Nov 2024.
Charges
A charge with Yes Bank Limited amounted to Rs. 15,000.00 Lakh with Charge ID 100988719 was registered on 23 Sep 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 15,000.00 Lakh with Charge ID 100957346 was registered on 31 Jul 2024.
Charges
A charge registered on 15 Jul 2022 via Charge ID 100593791 with Hdfc Bank Limited was fully satisfied on 12 Mar 2024.
Appointed
Srinivasa Ramachandra Rao Ilapakurthy was appointed as Director.
Appointed
Nityananda Reddy Kambam was appointed as Director.
Ceased
Sanjeev Indravadan Dani ceased to be Director.
Charges
A charge with Others of Rs. 125,000.00 Lakh registered on 30 Dec 2022 with Charge ID 100672468 was modified on 03 Mar 2023.

8 earlier events are in the company report.

Frequently asked questions

Lyfius Pharma is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 November 2020 (6+ years old) and is registered under CIN U24299AP2020PTC116443.

Lyfius Pharma has 5 current directors:

The latest financial statements of Lyfius Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 08 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Lyfius Pharma is 37AAECL4415B1ZX, registered in Andhra Pradesh.

The CIN (Corporate Identification Number) of Lyfius Pharma is U24299AP2020PTC116443. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Lyfius Pharma has 4 court cases on record: 3 filed by the company and 1 filed against it. 1 is pending.

Lyfius Pharma was incorporated on 16 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Vijayawada.

Bala Subramanyam Sami Reddy Palle Reddy was appointed as Additional Director on 14 Nov 2025. Srinivasa Ramachandra Rao Ilapakurthy was appointed as Director on 30 Jan 2024. Nityananda Reddy Kambam was appointed as Director on 01 Dec 2023. Lyfius Pharma has 9 board changes on record in total.

Lyfius Pharma has 6 MSME Form 1 returns on record between 2022 and 2024, listing 116 overdue payments to 47 micro and small suppliers. The latest return was filed on 30 Apr 2024.

Lyfius Pharma can be reached through the website aurobindo.com. Its registered office is in Visakhapatnam, Andhra Pradesh, India.

The registered office of Lyfius Pharma is at Unit 14 Jn Pharma City Plot No 17 Rno.10 11 & 19 20 E Bonangi Vlg, Visakhapatnam, Andhra Pradesh, India – 531021.